Grifols, a global healthcare company and leading producer of plasma-derived medicines, today announced it has received a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to ...

Delray Medical Center cut the ribbon on its newest high-tech machine that targets brain areas to treat movement disorders ...

A 47-year-old man was the first in the world to be treated outside of a study context with a new technique for the symptoms ...

Treatment with an oral allosteric modulator was nonsuperior to placebo at 6 weeks in adults with Parkinson’s disease whose ...

Parkinson's disease is a solvable problem, but only if we act decisively and urgently. We have the knowledge, and we've built ...

Learn how caffeine affects Parkinson's disease prevention and treatment. New research uncovers both protective benefits and treatment limitations.

In the past, Parkinson’s disease was primarily considered a disorder of the nervous system, centered in the brain. However, ...

A new discovery in blood immune cells has put researchers one step closer to identifying a blood biomarker that would allow ...

University of Arizona researchers revealed that dyskinesia in Parkinson’s patients stems from a disconnect in the motor ...

Researchers uncovered new findings about involuntary muscle movements that come with long-term administration of Parkinson's drug levodopa.

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

The US company has said it is launching the Phase III trials in the first half of this year after Phase I talks with the US ...